1353-5226 < 1353-8020 < 1353-8047

Facettes :

List of bibliographic references indexed by 1353-8020

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]

Ident.	Authors (with country if any)	Title
001997 (2001)	J. N. Joyce [États-Unis] ; H. Ryoo [États-Unis] ; E. V. Gurevich [États-Unis] ; C. Adler [États-Unis] ; T. Beach [États-Unis]	Ventral striatal D3 receptors and Parkinson's Disease
001A03 (2001)	W. J Weiner [États-Unis] ; S. A Factor [États-Unis] ; Joseph Jankovic [États-Unis] ; R. A Hauser [États-Unis] ; J. W Tetrud [États-Unis] ; C. H Waters [États-Unis] ; L. M Shulman [États-Unis] ; P. M Glassman [États-Unis] ; B. Beck [États-Unis] ; D. Paume [États-Unis] ; C. Doyle [États-Unis]	The long-term safety and efficacy of pramipexole in advanced Parkinson's disease
001A32 (2001)	P. K Pal [Canada] ; Z. K Wszolek [États-Unis] ; A. Kishore [Canada] ; R. De La Fuente-Fernandez [Canada] ; V. Sossi [Canada] ; R. J Uitti [États-Unis] ; T. Dobko [Canada] ; A. J Stoessl [Canada]	Positron emission tomography in pallido-ponto-nigral degeneration (PPND) family (frontotemporal dementia with parkinsonism linked to chromosome 17 and point mutation in tau gene)
001A50 (2001)	T. Caraceni [Italie] ; M. Musicco [Italie]	Levodopa or dopamine agonists, or deprenyl as initial treatment for Parkinson's disease. A randomized multicenter study
001A65 (2001)	N. Giladi [Israël] ; H. Shabtai [Israël] ; E. Rozenberg [Israël] ; E. Shabtai [Israël]	Gait festination in Parkinson's disease
001A68 (2001)	Masafumi Fukuda [États-Unis] ; Christine Edwards [États-Unis] ; David Eidelberg [États-Unis]	Functional brain networks in Parkinson's disease
001A75 (2001)	S. Giménez-Roldán [Espagne] ; D. Mateo [Espagne] ; E. Navarro [Espagne] ; M. M Ginés [Espagne]	Efficacy and safety of clozapine and olanzapine: an open-label study comparing two groups of Parkinson's disease patients with dopaminergic-induced psychosis
001A79 (2001)	Joseph Jankovic [États-Unis] ; Ron Tintner [États-Unis]	Dystonia and parkinsonism
001B09 (2001)	J.-J. M Askenasy [Israël]	Approaching disturbed sleep in late Parkinson's Disease: first step toward a proposal for a revised UPDRS
001B10 (2001)	P. K. Pal [Canada] ; C. S. Lee [Canada] ; A. Samii [Canada] ; M. Schulzer [Canada] ; A. J. Stoessl [Canada] ; E. K. Mak [Canada] ; J. Wudel [Canada] ; T. Dobko [Canada] ; J. K. C. Tsui [Canada]	Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET [18F]-DOPA Ki
001B14 (2001)	I. Milanov [Bulgarie]	A cross-over clinical and electromyographic assessment of treatment for parkinsonian tremor
001B89 (2000)	M. C. Schiess [États-Unis] ; H. Zheng [États-Unis] ; V. M. Soukup [États-Unis] ; J. G. Bonnen [États-Unis] ; H. J. W. Nauta [États-Unis]	Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis
001C08 (2000)	A. A. Rabinstein [États-Unis] ; L. M. Shulman [États-Unis, Niger]	Management of behavioral and psychiatric problems in Parkinson's disease
001C29 (2000)	R. Horowski [Allemagne] ; L. Horowski [Allemagne] ; S. M. Calne [Canada] ; D. B. Calne [Canada]	From Wilhelm von Humboldt to Hitler—are prominent people more prone to have Parkinson's disease?
001C34 (2000)	J. Lyytinen [Finlande] ; S. Kaakkola [Finlande] ; A. Gordin [Finlande] ; E.-R Kultalahti [Finlande] ; H. Ter V Inen [Finlande]	Entacapone and selegiline with l-dopa in patients with Parkinson's disease: an interaction study
001D22 (1999)	U. Bonuccelli [Italie] ; C. D'Avino [Italie] ; N. Caraccio [Italie] ; P. Del Guerra [Italie] ; A. Casolaro [Italie] ; N. Pavese [Italie] ; P. Del Dotto [Italie] ; F. Monzani [Italie]	Thyroid function and autoimmunity in Parkinson's disease: a study of 101 patients
001D32 (1999)	M. Nussbaum [Israël] ; T. A. Treves [Israël] ; R. Inzelberg [Israël] ; J. M. Rabey [Israël] ; A. D. Korczyn [Israël]	Survival in Parkinson's disease: the effect of dementia
001D48 (1999)	A. Wallin [Suède] ; C. Jennersjö [Suède] ; A.-K Granérus [Suède]	Prevalence of dementia and regional brain syndromes in long-standing Parkinson's disease
001D60 (1999)	M. B. Graeber [Allemagne] ; E. Grasbon-Frodl [Allemagne] ; P. Abell-Aleff [États-Unis] ; S. Kösel [Allemagne]	Nigral neurons are likely to die of a mechanism other than classical apoptosis in Parkinson's disease
001D85 (1999)	P. Jenner [Royaume-Uni]	Genetic susceptibility and the occurrence of Parkinson's disease
001E19 (1998)	Wolfgang H. Jost [Allemagne] ; Anke K. Bellon [Allemagne] ; Thomas Kaiser [Allemagne] ; Bertold Schrank [Allemagne]	The impact of ropinirole on blood pressure and noradrenaline concentration after active orthostasis in Parkinsonian patients

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "1353-8020" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "1353-8020" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1353-8020
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024